Codoxo Secures $35M Series C Led by CVS Health Ventures to Scale AI-Powered Healthcare Payment Integrity

Why It Matters

By shifting payment integrity upstream, Codoxo helps payers cut waste, lower administrative costs, and improve provider relationships, positioning the company as a strategic solution in a tightening healthcare cost environment.

Key Takeaways

• $35M Series C led by CVS Health Ventures
• AI prevents payment errors before claim creation
• Savings $12‑$16 per member annually, up to 40% overpayments cut
• Platform covers 80M lives, 100% customer retention
• New tools: Data Health Integrity Agent, Policy‑to‑Code AI

Pulse Analysis

Healthcare payers are grappling with soaring claim volumes and legacy audit processes that react after errors occur. Traditional payment‑integrity solutions rely on post‑payment reviews, which are costly and often miss systemic issues. Codoxo’s Point Zero approach flips this model by embedding generative AI at the earliest stage of the payment lifecycle, flagging potential discrepancies before a claim is ever submitted. This proactive stance not only curtails overpayments but also reduces the administrative burden of appeals, delivering measurable cost efficiencies for insurers, pharmacy benefit managers, and government programs.

The Series C infusion fuels Codoxo’s rapid product evolution. Recent releases such as the Data Health Integrity Agent streamline structured data exchange, while the Policy‑to‑Code engine translates payer policies into executable AI‑driven workflows, slashing manual configuration time. Security enhancements, including deep‑fake detection and ongoing HITRUST certification, address rising fraud concerns and pave the way for FedRAMP readiness, expanding access to federal customers. These innovations reinforce the platform’s unified cost‑containment promise, blending provider education, fraud detection, and compliance monitoring into a single, scalable solution.

Investor confidence, highlighted by CVS Health Ventures’ lead role, signals broader industry validation of prevention‑first payment integrity. With 80 million lives already on the platform, 100% customer retention, and net revenue retention exceeding 125%, Codoxo is poised for national expansion. As payers seek smarter, AI‑enabled tools to stem rising healthcare expenditures, Codoxo’s model offers a compelling blend of cost savings, operational clarity, and stronger payer‑provider relationships, likely shaping the next wave of payment‑integrity standards.

Deal Summary

Codoxo announced a $35 million Series C funding round led by CVS Health Ventures, with participation from Echo Health Ventures and existing investors. The capital will accelerate the rollout of its AI-driven payment integrity platform across U.S. healthcare payers, enhancing fraud detection and cost containment. The round underscores growing investor confidence in proactive, AI-powered healthcare finance solutions.